Exonics Therapeutics' Series A Round

Exonics Therapeutics raised a round of funding on November 09, 2017. Investors include The Column Group.

Exonics Therapeutics is a biotechnology company focusing on utilizing gene editing technologies like CRISPR/Cas9 to advance the development of a treatment for Duchenne muscular dystrophy. Exonics' CRI…

Articles about Exonics Therapeutics' Series A Round: